Survival imProvement in Lung cancEr iNduced by DenOsUmab theRapy
Clinical trial NCT02129699 · TERMINATED
Trial details
- NCT number
- NCT02129699
- Sponsor
- ETOP IBCSG Partners Foundation
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-06
- Primary completion
- 2020-02-29
- Enrollment
- 595
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.